KG NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Kestrel Group, Ltd. · Financial Services · Insurance - Reinsurance

Open interactive chart View report data Download investor PDF
Latest close 9.11 USD
-1.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -17.2% below the Trend Line and sits at 4.4% of its 52-week range. The latest completed week returned -1.0%, after a -4.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: earnings are due in 22d.

Setup score 26 out of 100
Latest Close 9.11 USD 24 Jul 2026
1W Return -1.0% latest completed week
4W Return -4.3% short-term follow-through
12W Return -4.2% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.0% Latest completed week; four-week move -4.3%. Indicator stack 0/52 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 10 relevant articles in the latest sentiment read. Event risk 22d Next report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -17.2% below the Trend Line and sits at 4.4% of its 52-week range. The latest completed week returned -1.0%, after a -4.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0812-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.3% over four weeks, -4.2% over 12 weeks, and -64.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-1.0%
4W-4.3%
12W-4.2%
26W-11.8%
52W-64.5%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.29Latest activity-pressure read.
Pressure change-43.8%Four-week change in activity pressure.
Leadership-47.46Latest relative-leadership reading.
RS change7.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength60/100Blend of value, momentum, and quality. Underlying universe rank 41; rank 1 is best.
Value93/100Relative valuation strength. Underlying universe rank 8; rank 1 is best.
Quality26/100Profitability and accounting quality. Underlying universe rank 75; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth78/100Revenue and earnings growth. Underlying universe rank 23; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
1.8x
Price divided by trailing earnings.
Price / sales
1.7x
Market value relative to trailing revenue.
EV / EBITDA
3.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-46.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
67.6%
Gross profit retained from each unit of revenue.
Operating margin
127.6%
Operating profit retained from revenue.
Free-cash-flow margin
-207.9%
Free cash flow generated from revenue.
Return on invested capital
16.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
415.6%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
56.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
56.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 10 relevant articles.

2 positive · 5 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings22dNext report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-71.2%Distance below the 52-week high.
13-week volatility10.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+24.8%Week of 8 May.
Worst week-31.2%Week of 13 Mar.
Latest week-1.0%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains6
Flat weeks0
Modest losses5
Sharp losses6
Recent vol10.4%13-week weekly-return volatility.
Base vol10.3%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew6.5% / -8.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.08; No reversal markers Factors45/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 58; Small Cap Core rank 5 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 10 relevant articles.

US Financial Stocks Positioned for Higher Rates and Faster Earnings Growth Insiders50/100

No recent insider transaction evidence is stored.

 Earnings22d

Next report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20269.11 USD-1.0%11.01 USD16.99 USD0.29-47.4692.7KOff
17 Jul 20269.20 USD-10.2%11.04 USD17.12 USD0.44-49.0378.1KOff
10 Jul 202610.25 USD0.9%11.09 USD17.25 USD0.61-46.6872.7KOff
3 Jul 202610.16 USD6.7%11.10 USD17.37 USD0.59-47.34125.2KOff
26 Jun 20269.52 USD-20.6%11.19 USD17.50 USD0.51-51.33304.9KOff
19 Jun 202611.99 USD2.7%11.37 USD17.64 USD0.48-42.9641.6KOff
12 Jun 202611.68 USD-2.1%11.47 USD17.74 USD0.35-44.1539.8KOff
5 Jun 202611.93 USD6.1%11.61 USD17.86 USD0.22-42.8623.9KOff
29 May 202611.24 USD1.8%11.82 USD17.97 USD0.22-49.6322.5KOff
22 May 202611.04 USD5.0%12.11 USD18.10 USD0.13-50.1623.2KOff
15 May 202610.51 USD-11.5%12.62 USD18.24 USD0.07-28.8KOff
8 May 202611.87 USD24.8%13.11 USD18.39 USD0.24-66.5KOff
1 May 20269.51 USD-3.2%13.56 USD18.52 USD0.25-81.2KOff
24 Apr 20269.82 USD-15.5%14.11 USD18.71 USD0.32-56.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.